The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
about
New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failureClinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic ShockDiagnosing sepsis - The role of laboratory medicine.What was old is new again: using the host response to diagnose infectious disease.Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test CombinationThe clinical value of biomarkers in respiratory complications in hematopoietic SCT.Comparison of diagnostic and prognostic utility of lactate and procalcitonin for sepsis in adult cancer patients presenting to emergency department with systemic inflammatory response syndrome.Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections.Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia.MR-proADM: A New Biomarker for Early Diagnosis of Sepsis in Burned Patients.Leveraging Clinical Time-Series Data for Prediction: A Cautionary Tale.The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis.Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review
P2860
Q28076596-E5EF0E57-288D-4CB9-BC1C-E591E6E17AFAQ28547939-AB7E36E4-22B5-4B7C-9D7D-4F2535C978BCQ30249127-D55572A0-DD4E-4585-B736-8FD9A635181FQ30376327-609EF75E-0951-4D1B-89C3-3DBD78B324B7Q35226677-23883D52-7033-4AE2-8220-BAD441E574CBQ36305283-EF7DD91F-4FBE-4EC4-82F0-45AE418F54A9Q40474709-45F3AE66-026B-44A3-B3AC-C76FB67E6B07Q40653938-F4AD0170-7CCB-486E-8202-95A9F84CC59CQ41172929-A23F140A-3267-4A34-8517-800AC5C90989Q49184626-A556763C-5488-4B3C-9F07-13395F6C8592Q52841505-A82BAE7E-DE10-437D-B7D3-E97CACD3A171Q54943285-BFAE1509-8759-4941-9D0C-9A022CDE609DQ55014096-27F33CEA-DBAC-4B78-ADDA-8C71B172CDE6Q55052450-743B018E-0B72-4D28-AA8A-909264C3EE6FQ58766368-5426CC80-DF66-457C-884B-C633CDE76F5C
P2860
The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The utility of proadrenomedull ...... lly ill patients with cancer*.
@en
type
label
The utility of proadrenomedull ...... lly ill patients with cancer*.
@en
prefLabel
The utility of proadrenomedull ...... lly ill patients with cancer*.
@en
P2093
P1476
The utility of proadrenomedull ...... ally ill patients with cancer*
@en
P2093
Anne-Marie Chaftari
Iba Al Wohoush
Issam Raad
Joseph Jabbour
Labib Debiane
Munirah Al Shuaibi
Philipp Schuetz
Ramez R Bahu
Ray Y Hachem
S Egbert Pravinkumar
P304
P356
10.1097/CCM.0000000000000526
P407
P577
2014-12-01T00:00:00Z